Scientists have identified a protein, nicknamed "Mitch" (MTCH2), that plays a significant role in cellular energy management and fat storage. New research suggests that disabling this protein could dramatically increase the body's ability to burn carbohydrates and fat while simultaneously blocking the creation of new fat cells.
This discovery is particularly significant as it may offer a novel approach to obesity treatment that could circumvent a common side effect of current weight loss drugs: muscle mass loss. The breakthrough, developed over several years by researchers at the Weizmann Institute of Science, began with studies on mice. When the production of Mitch was suppressed in the mice's muscle tissue, they exhibited remarkable resistance to obesity. They also developed more muscle fibers, suggesting enhanced stamina and athletic performance, and performed better under physical stress.
Further investigations into human cells revealed similar effects. Removing Mitch effectively simulated a state of constant energy shortage within the cells. To compensate, the cells ramped up their metabolism, burning significantly more fats, carbohydrates, and amino acids. This process shifted the cells' primary fuel source from carbohydrates and proteins to fat, indicating that Mitch acts as a metabolic regulator determining whether fat is stored or utilized for energy.
"We discovered that deleting Mitch led to a major drop in fats in membranes," explained co-author Atan Gross. "At the same time, we saw an increase in fatty substances used to produce energy, and we realized that the fat was being broken down from the membrane to be used as fuel. In other words, we showed that Mitch determines the fate of fat in human cells."
The research also uncovered that Mitch influences the formation of new fat cells. When the protein was removed from progenitor cells—immature cells capable of developing into mature fat-storing cells—the creation of new fat cells was significantly hindered. The cells appeared unable to create an environment conducive to fat synthesis.
"When we deleted Mitch from the progenitor cells, we discovered that the environment created in these cells was not conducive to the synthesis of new fats," Gross stated. "We showed that Mitch determines the fate of fat in human cells."
While these findings are promising for the development of future therapies aimed at increasing fat burning, preventing fat cell formation, and preserving muscle mass, much more research is required. Scientists need to determine the safety and efficacy of targeting this protein in humans before any therapeutic applications can be considered.